APPLE TREE PARTNERS II LP

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$6.09M

Insider Activity of APPLE TREE PARTNERS II LP

The largest sale of all time was on 2018-01-09 and amounted to 300000 shares of Aileron Therapeutics, Inc. for $2.94M.

Biography of APPLE TREE PARTNERS II LP

No biography is available at this moment.

2018-06-26SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
10,528
0.0737%
$5.45$57,425-63.52%
2018-06-25SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
913
0.0063%
$5.86$5,353-66.32%
2018-06-22SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
189,632
1.2734%
$5.98$1.13M-67.88%
2018-06-21SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
2,894
0.0173%
$5.30$15,338-67.77%
2018-06-20SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
10,400
0.0708%
$5.30$55,127-63.07%
2018-06-19SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
278
0.0019%
$5.30$1,473-62.67%
2018-06-18SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
2,864
0.0198%
$5.35$15,322-62.48%
2018-06-15SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
15,922
0.1074%
$5.32$84,691-63.18%
2018-06-12SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
21,686
0.1564%
$5.40$117,115-60.63%
2018-06-11SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
37,050
0.2529%
$5.41$200,485-62.83%
2018-06-08SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
19,234
0.1316%
$5.40$103,925-62.69%
2018-06-07SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
40
0.0003%
$5.47$219-63.03%
2018-04-19SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
209,598
1.4892%
$6.29$1.32M-61.9%
2018-04-17SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
6,210
0.0425%
$7.05$43,781-66.67%
2018-01-09SaleAileron Therapeutics, Inc.
ALRN
10 percent owner
300,000
1.9362%
$9.80$2.94M-51.7%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.